Literature DB >> 15357268

[A case of successful desensitization therapy for isoniazid-induced pneumonitis].

Yoriko Nishizawa1, Masahide Yasui, Chihiro Yamamori, Atsurou Tagami, Masaki Fujimura, Shinji Nakao.   

Abstract

A 65-year-old man was admitted to hospital for treatment of pulmonary tuberculosis. He was treated with isoniazid (INH), rifampicin (RFP), ethambutol (EB), and pyrazinamide (PZA). On the 14th day, he developed a fever and interstitial pneumonia, which improved promptly after discontinuation of the antituberculous drugs. Drug lymphocyte stimulation tests against INH, RFP and PZA were negative. However, the provocation test on INH (only) was positive, leading to a diagnosis of pneumonitis caused by INH. We then tried desensitization of INH over a period of two weeks, which was successful and occurred without any clinical event. In the past, five cases of INH-induced pneumonitis were reported, but desensitization of INH did not occur in any. We conclude that physicians should be aware not only of paradoxical reactions but also of drug-induced pneumonitis when a new pulmonary infiltrate develops in the course of tuberculosis treatment. Furthermore, drug desensitization may be possible in some cases of drug-induced pneumonitis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15357268

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  3 in total

1.  Development of interstitial pneumonia in a patient with rheumatoid arthritis induced by isoniazid for tuberculosis chemoprophylaxis.

Authors:  Kiyoshi Migita; Tetsuya Umeno; Kana Miyagawa; Yasumori Izumi; Eisuke Sasaki; Tomoyuki Kakugawa; Masahiro Ito; Akitoshi Kinoshita; Taichiro Miyashita
Journal:  Rheumatol Int       Date:  2010-03-27       Impact factor: 2.631

2.  Isoniazid and pulmonary fibrosis.

Authors:  Chae Uk Chung; Dong Il Park; Choong Sik Lee; Sung Soo Jung
Journal:  Chin Med J (Engl)       Date:  2015-03-05       Impact factor: 2.628

3.  A retrospective study on sequential desensitization-rechallenge for antituberculosis drug allergy.

Authors:  Bernard Yu-Hor Thong; Faith Li-Ann Chia; Sze-Chin Tan; Teck-Choon Tan; Khai-Pang Leong; Justina Wei-Lyn Tan; Chwee-Ying Tang; Jin-Feng Hou; Grace Yin-Lai Chan; Hiok-Hee Chng
Journal:  Asia Pac Allergy       Date:  2014-07-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.